Professor Jean-Claude Heuson founded a breast cancer research laboratory in 1960 at the 
Jules Bordet Institute. When he died unexpectedly in 1986, his family and friends donated 
funds to the breast cancer unit to ensure that his work would continue. Thus was born the 
Jean-Claude Heuson Fund to promote research in breast cancer.

The objective of the Heuson Fund is to support fundamental research, translational 
research, and clinical research in breast cancer. In the field of fundamental research, 
the Heuson Fund provides support to the J.C. Heuson Laboratory of Breast Cancer 
Research, directed by Professor Leclercq, which focuses its research on estrogen 
receptors and their genetic role in breast cancer. The Translational Research Unit (TRU) 
focuses on finding biological markers of prognostic and predictive value, and on the 
mechanisms of resistance and response to therapy. The aim is to better individualize 
the treatment of breast, and other cancer, patients. TRU works in close collaboration 
with the Functional Genomic Unit directed by Dr. Sotiriou and also supported by the 
Heuson Fund. This laboratory - created in 2001 - is a leader in the research and 
identification of DNA markers and defining the gene profile of individual tumors.

Further, the Jean-Claude Heuson Fund supports the clinical research on breast cancer 
directed by Professor M. Piccart-Gebhart in the Bordet Institute.

Sponsor :                                                                                                                                                                                                          _{© C. Bleiman - 2008 - Last modified on 2012-01-24}  

                                                                                                                                                                                                    Send mail to webmaster@heuson.be with questions or comments about this web site.